# ICF International, Inc.: financial statements, quarterly

ICFI · Nasdaq · CIK 1362004 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/icfi.md) · [Financials](/companies/icfi/financials.md) · [Filings](/companies/icfi/filings.md) · [Insiders](/companies/icfi/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/icfi/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q1 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [502](/filings/0000950170-24-119787.md) | [478 d](/filings/0001193125-26-082536.md) | [494](/filings/0000950170-25-062246.md) | [512](/filings/0000950170-25-101092.md) | [517](/filings/0001193125-25-258806.md) | [496 d](/filings/0001193125-26-082536.md) | [488](/filings/0001193125-26-212358.md) | [476](/filings/0001193125-26-338422.md) | [465](/filings/0001193125-25-258806.md) | [444 d](/filings/0001193125-26-082536.md) | [438](/filings/0001193125-26-212358.md) | [474](/filings/0001193125-26-338422.md) |
| Cost of revenue | $m | [324](/filings/0000950170-24-119787.md) | [304 d](/filings/0001193125-26-082536.md) | [311](/filings/0000950170-25-062246.md) | [329](/filings/0000950170-25-101092.md) | [325](/filings/0001193125-25-258806.md) | [317 d](/filings/0001193125-26-082536.md) | [303](/filings/0001193125-26-212358.md) | [298](/filings/0001193125-26-338422.md) | [291](/filings/0001193125-25-258806.md) | [285 d](/filings/0001193125-26-082536.md) | [271](/filings/0001193125-26-212358.md) | [298](/filings/0001193125-26-338422.md) |
| Selling, general and administrative | $m | [132](/filings/0000950170-24-119787.md) | [123 d](/filings/0001193125-26-082536.md) | [129](/filings/0000950170-25-062246.md) | [127](/filings/0000950170-25-101092.md) | [133](/filings/0001193125-25-258806.md) | [129 d](/filings/0001193125-26-082536.md) | [132](/filings/0001193125-26-212358.md) | [123](/filings/0001193125-26-338422.md) | [122](/filings/0001193125-25-258806.md) | [115 d](/filings/0001193125-26-082536.md) | [119](/filings/0001193125-26-212358.md) | [123](/filings/0001193125-26-338422.md) |
| Operating income | $m | [31.9](/filings/0000950170-24-119787.md) | [36.9 d](/filings/0001193125-26-082536.md) | [40.9](/filings/0000950170-25-062246.md) | [42.4](/filings/0000950170-25-101092.md) | [46.0](/filings/0001193125-25-258806.md) | [36.5 d](/filings/0001193125-26-082536.md) | [38.4](/filings/0001193125-26-212358.md) | [40.0](/filings/0001193125-26-338422.md) | [38.4](/filings/0001193125-25-258806.md) | [28.6 d](/filings/0001193125-26-082536.md) | [34.9](/filings/0001193125-26-212358.md) | [39.9](/filings/0001193125-26-338422.md) |
| Interest expense | $m | not reported | not reported | [8.3](/filings/0000950170-25-062246.md) | [7.8](/filings/0000950170-25-101092.md) | [7.2](/filings/0001193125-25-258806.md) | [6.6 d](/filings/0001193125-26-082536.md) | [7.4](/filings/0001193125-26-212358.md) | [8.5](/filings/0001193125-26-338422.md) | [7.9](/filings/0001193125-25-258806.md) | [7.4 d](/filings/0001193125-26-082536.md) | [6.8](/filings/0001193125-26-212358.md) | [6.9](/filings/0001193125-26-338422.md) |
| Income tax | $m | [0.3](/filings/0000950170-24-119787.md) | [7.6 d](/filings/0001193125-26-082536.md) | [7.0](/filings/0000950170-25-062246.md) | [9.1](/filings/0000950170-25-101092.md) | [5.3](/filings/0001193125-25-258806.md) | [6.5 d](/filings/0001193125-26-082536.md) | [3.2](/filings/0001193125-26-212358.md) | [6.3](/filings/0001193125-26-338422.md) | [7.0](/filings/0001193125-25-258806.md) | [4.0 d](/filings/0001193125-26-082536.md) | [6.9](/filings/0001193125-26-212358.md) | [5.8](/filings/0001193125-26-338422.md) |
| Net income | $m | [23.7](/filings/0000950170-24-119787.md) | [22.2 d](/filings/0001193125-26-082536.md) | [27.3](/filings/0001193125-25-258806.md) | [25.6](/filings/0001193125-25-258806.md) | [32.7](/filings/0001193125-25-258806.md) | [24.6 d](/filings/0001193125-26-082536.md) | [26.9](/filings/0001193125-26-338422.md) | [23.7](/filings/0001193125-26-338422.md) | [23.8](/filings/0001193125-25-258806.md) | [17.3 d](/filings/0001193125-26-082536.md) | [20.5](/filings/0001193125-26-338422.md) | [26.9](/filings/0001193125-26-338422.md) |
| Diluted EPS | $ per share | [1.25](/filings/0000950170-24-119787.md) | not reported | [1.44](/filings/0000950170-25-062246.md) | [1.36](/filings/0000950170-25-101092.md) | [1.73](/filings/0001193125-25-258806.md) | not reported | [1.44](/filings/0001193125-26-212358.md) | [1.28](/filings/0001193125-26-338422.md) | [1.28](/filings/0001193125-25-258806.md) | not reported | [1.12](/filings/0001193125-26-212358.md) | [1.49](/filings/0001193125-26-338422.md) |
| Basic EPS | $ per share | [1.26](/filings/0000950170-24-119787.md) | not reported | [1.46](/filings/0000950170-25-062246.md) | [1.37](/filings/0000950170-25-101092.md) | [1.74](/filings/0001193125-25-258806.md) | not reported | [1.45](/filings/0001193125-26-212358.md) | [1.29](/filings/0001193125-26-338422.md) | [1.29](/filings/0001193125-25-258806.md) | not reported | [1.12](/filings/0001193125-26-212358.md) | [1.50](/filings/0001193125-26-338422.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q1 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [5.1](/filings/0000950170-24-119787.md) | [6.4](/filings/0001193125-26-082536.md) | [3.7](/filings/0000950170-25-062246.md) | [4.1](/filings/0000950170-25-101092.md) | [6.9](/filings/0001193125-25-258806.md) | [5.0](/filings/0001193125-26-082536.md) | [5.7](/filings/0001193125-26-212358.md) | [7.0](/filings/0001193125-26-338422.md) | [4.0](/filings/0001193125-25-258806.md) | [5.3](/filings/0001193125-26-338422.md) | [3.9](/filings/0001193125-26-212358.md) | [4.6](/filings/0001193125-26-338422.md) |
| Current assets | $m | [477](/filings/0000950170-23-058490.md) | [447](/filings/0000950170-25-029917.md) | [466](/filings/0000950170-24-051572.md) | [465](/filings/0000950170-24-089575.md) | [493](/filings/0000950170-24-119787.md) | [492](/filings/0001193125-26-082536.md) | [511](/filings/0000950170-25-062246.md) | [506](/filings/0000950170-25-101092.md) | [569](/filings/0001193125-25-258806.md) | [514](/filings/0001193125-26-338422.md) | [524](/filings/0001193125-26-212358.md) | [579](/filings/0001193125-26-338422.md) |
| Total assets | $m | [2,055](/filings/0000950170-23-058490.md) | [2,012](/filings/0000950170-25-029917.md) | [2,018](/filings/0000950170-24-051572.md) | [2,006](/filings/0000950170-24-089575.md) | [2,028](/filings/0000950170-24-119787.md) | [2,066](/filings/0001193125-26-082536.md) | [2,075](/filings/0000950170-25-062246.md) | [2,074](/filings/0000950170-25-101092.md) | [2,114](/filings/0001193125-25-258806.md) | [2,050](/filings/0001193125-26-338422.md) | [2,053](/filings/0001193125-26-212358.md) | [2,098](/filings/0001193125-26-338422.md) |
| Current liabilities | $m | [369](/filings/0000950170-23-058490.md) | [418](/filings/0000950170-25-029917.md) | [393](/filings/0000950170-24-051572.md) | [392](/filings/0000950170-24-089575.md) | [408](/filings/0000950170-24-119787.md) | [449](/filings/0001193125-26-082536.md) | [382](/filings/0000950170-25-062246.md) | [393](/filings/0000950170-25-101092.md) | [403](/filings/0001193125-25-258806.md) | [404](/filings/0001193125-26-338422.md) | [355](/filings/0001193125-26-212358.md) | [418](/filings/0001193125-26-338422.md) |
| Total liabilities | $m | [1,162](/filings/0000950170-23-058490.md) | [1,094](/filings/0000950170-25-029917.md) | [1,102](/filings/0000950170-24-051572.md) | [1,062](/filings/0000950170-24-089575.md) | [1,052](/filings/0000950170-24-119787.md) | [1,084](/filings/0001193125-26-082536.md) | [1,106](/filings/0000950170-25-062246.md) | [1,074](/filings/0000950170-25-101092.md) | [1,089](/filings/0001193125-25-258806.md) | [1,022](/filings/0001193125-26-338422.md) | [1,021](/filings/0001193125-26-212358.md) | [1,048](/filings/0001193125-26-338422.md) |
| Long-term debt | $m | [511](/filings/0000950170-23-058490.md) | [404](/filings/0000950170-25-029917.md) | [449](/filings/0000950170-24-051572.md) | [422](/filings/0000950170-24-089575.md) | [405](/filings/0000950170-24-119787.md) | [412](/filings/0001193125-26-082536.md) | [502](/filings/0000950170-25-062246.md) | [462](/filings/0000950170-25-101092.md) | [449](/filings/0001193125-25-258806.md) | [401](/filings/0001193125-26-338422.md) | [439](/filings/0001193125-26-212358.md) | [406](/filings/0001193125-26-338422.md) |
| Current portion of debt | $m | [23.3](/filings/0000950170-23-058490.md) | [26.0](/filings/0000950170-25-029917.md) | [26.0](/filings/0000950170-24-051572.md) | [12.4](/filings/0000950170-24-089575.md) | [13.8](/filings/0000950170-24-119787.md) | [0.0](/filings/0001193125-25-258806.md) | [0.0](/filings/0000950170-25-062246.md) | [0.0](/filings/0000950170-25-101092.md) | [0.0](/filings/0001193125-25-258806.md) | [1.4](/filings/0001193125-26-338422.md) | not reported | [1.4](/filings/0001193125-26-338422.md) |
| Shareholders' equity | $m | [893](/filings/0000950170-24-119787.md) | [918](/filings/0001193125-26-082536.md) | [916](/filings/0001193125-25-258806.md) | [943](/filings/0001193125-25-258806.md) | [976](/filings/0001193125-25-258806.md) | [982](/filings/0001193125-26-338422.md) | [969](/filings/0001193125-26-338422.md) | [1,000](/filings/0001193125-26-338422.md) | [1,024](/filings/0001193125-25-258806.md) | [1,028](/filings/0001193125-26-338422.md) | [1,032](/filings/0001193125-26-338422.md) | [1,050](/filings/0001193125-26-338422.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent, us-gaap:DebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [25.7 d](/filings/0000950170-24-119787.md) | [107 d](/filings/0001193125-26-082536.md) | [(10.0)](/filings/0000950170-25-062246.md) | [60.6 d](/filings/0000950170-25-101092.md) | [25.5 d](/filings/0001193125-25-258806.md) | [95.4 d](/filings/0001193125-26-082536.md) | [(33.0)](/filings/0001193125-26-212358.md) | [52.0 d](/filings/0001193125-26-338422.md) | [47.3 d](/filings/0001193125-25-258806.md) | [75.6 d](/filings/0001193125-26-082536.md) | [(3.1)](/filings/0001193125-26-212358.md) | [99.7 d](/filings/0001193125-26-338422.md) |
| Capital expenditure | $m | [4.7 d](/filings/0000950170-24-119787.md) | [4.5 d](/filings/0001193125-26-082536.md) | [5.2](/filings/0000950170-25-062246.md) | [5.2 d](/filings/0000950170-25-101092.md) | [5.2 d](/filings/0001193125-25-258806.md) | [5.9 d](/filings/0001193125-26-082536.md) | [3.5](/filings/0001193125-26-212358.md) | [5.8 d](/filings/0001193125-26-338422.md) | [5.5 d](/filings/0001193125-25-258806.md) | [6.9 d](/filings/0001193125-26-082536.md) | [2.8](/filings/0001193125-26-212358.md) | [5.7 d](/filings/0001193125-26-338422.md) |
| Dividends paid | $m | [2.6 d](/filings/0000950170-24-119787.md) | [2.6 d](/filings/0001193125-26-082536.md) | [2.6](/filings/0000950170-25-062246.md) | [2.6 d](/filings/0000950170-25-101092.md) | [2.6 d](/filings/0001193125-25-258806.md) | [2.6 d](/filings/0001193125-26-082536.md) | [2.6](/filings/0001193125-26-212358.md) | [2.6 d](/filings/0001193125-26-338422.md) | [2.6 d](/filings/0001193125-25-258806.md) | [2.6 d](/filings/0001193125-26-082536.md) | [2.6](/filings/0001193125-26-212358.md) | [2.5 d](/filings/0001193125-26-338422.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q1 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [19.0](/filings/0000950170-23-058490.md) | [18.9](/filings/0000950170-24-051572.md) | [18.9](/filings/0000950170-24-089575.md) | [19.0](/filings/0000950170-24-119787.md) | [18.9](/filings/0000950170-25-062246.md) | [18.9](/filings/0000950170-25-101092.md) | [18.9](/filings/0001193125-25-258806.md) | [18.6](/filings/0001193125-26-212358.md) | [18.5](/filings/0001193125-26-338422.md) | [18.5](/filings/0001193125-25-258806.md) | [18.3](/filings/0001193125-26-212358.md) | [18.0](/filings/0001193125-26-338422.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 17,933,884 at 2026-07-31, from the cover of the [10-Q filed 2026-08-06](/filings/0001193125-26-338422.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:37 ET. No prices; not investment advice.